OTC: JWCTF - JW (Cayman) Therapeutics Co. Ltd

छह महीने के लिए लाभप्रदता: +16.7%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम JW (Cayman) Therapeutics Co. Ltd

उन्नत शेड्यूल सरल ग्राफ
Financial Markets by TradingView

कंपनी के बारे में

JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in the People's Republic of China. It offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate is Carteyva (relmacabtagene autoleucel), an anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy for the treatment of a range of hematological cancers.

अधिक जानकारी
The company's pipeline products include JWCAR129, an autologous CAR-T therapy for the treatment of multiple myeloma; JWATM204, a TCR T-cell therapy candidate for the treatment of HCC; and JWATM203, an autologous T-cell receptor mimic T-cell therapy targeting alpha-fetoprotein for the treatment of hepatocellular carcinoma. JW (Cayman) Therapeutics Co. Ltd was founded in 2016 and is headquartered in Shanghai, China.
तुलना सूची में जोड़ें
घड़ी सूची में जोड़ें
पोर्टफोलियो में जोड़ें
मूल्य सूचना जोड़ें

EBITDA -0.3143
EV/EBITDA 0.5634
Industry Biotechnology
P/BV 1.82
P/S 164.53
Sector Health Care
Валюта usd
Валюта отчета cny
Выручка 0.0055
Сайт https://www.jwtherapeutics.com
Цена ао 0.255
Число акций ао 0.41153 млрд
प्रति दिन मूल्य परिवर्तन: 0% (0.255)
प्रति सप्ताह मूल्य परिवर्तन: 0% (0.255)
प्रति माह मूल्य परिवर्तन: +57.41% (0.162)
3 महीने में कीमत में बदलाव: -10.53% (0.285)
छह महीने में कीमत में बदलाव: +16.7% (0.2185)
प्रति वर्ष मूल्य परिवर्तन: +1.88% (0.2503)
3 वर्षों में मूल्य परिवर्तन: -89.8% (2.5)
वर्ष की शुरुआत से मूल्य परिवर्तन: -14.77% (0.2992)
सभी पैरामीटर

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 4.52 3
P/BV 0.4665 10
P/E 0 0
EV/EBITDA -0.2077 0
कुल: 5.38

क्षमता

नाम अर्थ श्रेणी
ROA, % -35.79 0
ROE, % -45.61 0
कुल: 0

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 0 0
कुल: 0

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA -0.588 10
कुल: 9.6

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % 3070.82 10
लाभप्रदता Ebitda, % 50.67 7
लाभप्रदता EPS, % 9.47 2
कुल: 5.6
अधिक जानकारी

संस्थानों आयतन शेयर करना, %
DFA Emerging Markets Small Cap Series 467500 0.11
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund 336309 0.08
DFA Emerging Markets Core Equity Portfolio 98500 0.02
Dimensional ETF Tr-Dimensional Emerging Markets Core Equity 2 ETF 95500 0.02
SPDR (R) Idx Shares-SPDR (R) S&P (R) China ETF 76500 0.02
Dimensional ETF Tr-Dimensional World ex U.S. Core Equity 2 ETF 69500 0.02
DFA Investment Dimensions-World Ex U.S. Core Equity Port 55500 0.01
SPDR (R) Idx Shares-SPDR (R) Emerging Markets Small Cap ETF 42350 0.01
DFA Investment Dimensions-DFA Emerging Markets Targeted Value Port 38000 0.01
Avantis Emerging Markets Equity ETF 36000 0.01



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Dr. Yiping Li M.D. Co-Founder & Interim Chairman 836.74k 1964 (60 साल)
Cao Xiaoping Ph.D. Senior Vice President of Tech Operations N/A
Dr. Shaun Paul Cordoba Ph.D. Senior VP & Chief Scientific Officer N/A 1980 (44 वर्ष)
Mr. Raymond J. Hage Jr. Senior Vice President of Corporate Development N/A 1968 (56 साल)
Mr. Mark J. Gilbert M.D. Senior Advisor & Acting Chief Medical Officer N/A
Ms. Ka Man Ng A.C.I.S., A.C.S. Company Secretary N/A 1978 (46 साल)
Mr. Qiang Ma Senior VP & Chief Commercial Officer N/A 1978 (46 साल)
Ms. Yun Qin Senior Vice President of Clinical Sciences & Medical Services N/A 1982 (42 वर्ष)
Dr. Su Yang Senior Vice President Of Clinical Research & PMO N/A 1979 (45 साल)
Mr. Min Liu CEO & Executive Director 1973 (51 वर्ष)

पता: China, Shanghai, Building B - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.jwtherapeutics.com